Author

Magdalini Panagiotakopoulou

Memorial Sloan Kettering Cancer CenterORCID 0000-0001-6293-4579Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alan M. HanashiD· 1 shared Anastasia I. KousaiD· 1 shared Anastasiya Egorova· 1 shared Ashley N. Sullivan· 1 shared Brianna GipsoniD· 1 shared Daniel A. HelleriD· 1 shared Edgar A. JaimesiD· 1 shared Emma Grabarnik· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alan M. HanashORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringbioRxivPreprintNov 19, 2025

Galectin-3 is a Nanotherapeutic Target in Graft-versus-Host Disease Mediated Kidney Injury

Magdalini Panagiotakopoulou, Ashley N. Sullivan, Kimon V. Argyropoulos…·Daniel A. Heller

The paper identifies galectin-3 as a target for nanotherapeutic delivery of ruxolitinib to reduce GVHD-related kidney injury and systemic inflammation.

DOI 10.1101/2025.11.19.688972

mouseexperimental assay